Insights

Compulsory licensing in Germany – the coronavirus crisis and beyond

by Dr. Anja Lunze, LL.M.

Does not patenting COVID-19 vaccines help third world countries?

Available in Hungarian

by Zoltán Novák, Ph.D.

Russian coronavirus vaccine – approval process in Hungary and the EU

Available in Hungarian

by Zoltán Novák, Ph.D.

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

by multiple authors

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

by multiple authors

Patent law in emergency situations

by David Mulder

UK brand owners prejudiced at EUIPO by combination of COVID-19 and Brexit

by Roland Mallinson

COVID-19 and Patent Law

Q&A regarding compulsory licenses and governmental use

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

End to automatic extension of UKIPO deadlines

by Louise Popple

The EU moves towards a data-agile economy

by Mark Owen and Maria Luchian

COVID-19 postponement of MDR implementation date – how does this fit with Brexit?

by Adrian Toutoungi

COVID-19: Courts and IP offices in the Netherlands

by Dr. Wim Maas and Maarten Rijks